UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Molecular cancer, 2023-08, Vol.22 (1), p.124-124, Article 124

2023

Volltextzugriff (PDF)

Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023

Portal hypertension & cirrhosis (Print), 2024-09, Vol.3 (3), p.139-159

2024

Volltextzugriff (PDF)

CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study

Cancer medicine (Malden, MA), 2018-07, Vol.7 (7), p.3011-3021

2018

Volltextzugriff (PDF)

Circulating endothelial cells and tumor blood volume as predictors in lung cancer

Cancer science, 2013-04, Vol.104 (4), p.445-452

2013

Volltextzugriff (PDF)

Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension

Frontiers in medicine, 2022-09, Vol.9, p.960316-960316

2022

Volltextzugriff (PDF)

A phase I study of anlotinib with concurrent chemoradiotherapy for limited-stage small cell lung cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8579-8579

2022

Volltextzugriff (PDF)

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2011-04, Vol.67 (4), p.955-961

2011

Volltextzugriff (PDF)

Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations (ALTER-L004)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9573-9573

2020

Volltextzugriff (PDF)

XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a

Cancer letters, 2021-04, Vol.503, p.197-212

2021

Volltextzugriff (PDF)

Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements

Medical science monitor, 2019-01, Vol.25, p.675-690

2019

Volltextzugriff (PDF)

Prognostic Significance of Combined Biomarkers in Small Cell Lung Cancer

Clinical laboratory (Heidelberg), 2020-01, Vol.66 (9)

2020

Volltextzugriff (PDF)

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level

Journal of Cancer, 2017-01, Vol.8 (16), p.3251-3260

2017

Volltextzugriff (PDF)

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer

EBioMedicine, 2023-05, Vol.91, p.104564-104564, Article 104564

2023

Volltextzugriff (PDF)

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancerResearch in context

EBioMedicine, 2023-05, Vol.91, p.104564

2023

Volltextzugriff (PDF)

Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma

Molecular diagnosis & therapy, 2011-12, Vol.15 (6), p.347-352

2011

Volltextzugriff (PDF)

Level of activated circulating endothelial cells to predict progression-free survival of Anlotinib treatment in patients with NSCLC: Analysis on ALTER-0303 study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20530-e20530

2017

Volltextzugriff (PDF)

Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma

Molecular diagnosis & therapy, 2011-12, Vol.15 (6), p.347

2011

Volltextzugriff (PDF)

Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor

Thoracic cancer, 2014-09, Vol.5 (5), p.438-446

2014

Volltextzugriff (PDF)

Incidence and clinical implication of tumor cavitation in patients with advanced non‐small cell lung cancer induced by E ndostar, an angiogenesis inhibitor

Thoracic cancer, 2014-09, Vol.5 (5), p.438-446

2014

Volltextzugriff (PDF)

Stabilizing the Nanostructure of SnO2 Anodes by Transition Metals: A Route to Achieve High Initial Coulombic Efficiency and Stable Capacities for Lithium Storage

Advanced materials (Weinheim), 2017-04, Vol.29 (13), p.n/a

2017

Volltextzugriff (PDF)

Improvement of electrochemical reversibility of the Ni-Rich cathode material by gallium doping

Journal of power sources, 2020-01, Vol.445, p.227337, Article 227337

2020

Volltextzugriff (PDF)

A green and efficient synthetic strategy for the preparation of PBS ionomers with high molecular weight, high ionic group content and good combined properties

Chemical engineering journal (Lausanne, Switzerland : 1996), 2023-12, Vol.477, p.146275, Article 146275

2023

Volltextzugriff (PDF)

Block-Wisely Supervised Neural Architecture Search With Knowledge Distillation

2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2020, p.1986-1995

2020

Volltextzugriff (PDF)

Synthesis and Properties of Polybutylene (Succinate)‑b‑poly(dimethylsiloxane) with Unprecedented Combined Performance and Functions

Biomacromolecules, 2023-12, Vol.24 (12), p.5951-5963

2023

Volltextzugriff (PDF)

Utilization of diatomite/chitosan–Fe (III) composite for the removal of anionic azo dyes from wastewater: Equilibrium, kinetics and thermodynamics

Colloids and surfaces. A, Physicochemical and engineering aspects, 2015-03, Vol.468, p.129-139

2015

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023

CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study

Circulating endothelial cells and tumor blood volume as predictors in lung cancer

Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension

A phase I study of anlotinib with concurrent chemoradiotherapy for limited-stage small cell lung cancer

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations (ALTER-L004)

XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a

Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements

Prognostic Significance of Combined Biomarkers in Small Cell Lung Cancer

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancerResearch in context

Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma

Level of activated circulating endothelial cells to predict progression-free survival of Anlotinib treatment in patients with NSCLC: Analysis on ALTER-0303 study

Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma

Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor

Incidence and clinical implication of tumor cavitation in patients with advanced non‐small cell lung cancer induced by E ndostar, an angiogenesis inhibitor

Stabilizing the Nanostructure of SnO2 Anodes by Transition Metals: A Route to Achieve High Initial Coulombic Efficiency and Stable Capacities for Lithium Storage

Improvement of electrochemical reversibility of the Ni-Rich cathode material by gallium doping

A green and efficient synthetic strategy for the preparation of PBS ionomers with high molecular weight, high ionic group content and good combined properties

Block-Wisely Supervised Neural Architecture Search With Knowledge Distillation

Synthesis and Properties of Polybutylene (Succinate)‑b‑poly(dimethylsiloxane) with Unprecedented Combined Performance and Functions

Utilization of diatomite/chitosan–Fe (III) composite for the removal of anionic azo dyes from wastewater: Equilibrium, kinetics and thermodynamics

Suchergebnisse filtern